Authors: Mwanjewe, J Spitaler, M Ebner, M Windegger, M Geiger, M Kampfer, S Hofmann, J Uberall, F Grunicke, HH

Citation: J. Mwanjewe et al., Regulation of phospholipase D isoenzymes by transforming Ras and atypical protein kinase C-iota, BIOCHEM J, 359, 2001, pp. 211-217

Authors: Kampfer, S Windegger, M Hochholdinger, F Schwaiger, W Pestell, RG Baier, G Grunicke, HH Uberall, F

Citation: S. Kampfer et al., Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras-1, J BIOL CHEM, 276(46), 2001, pp. 42834-42842

Authors: Hochholdinger, F Baier, G Nogalo, A Bauer, B Grunicke, HH Uberall, F

Citation: F. Hochholdinger et al., Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells, MOL CELL B, 19(12), 1999, pp. 8052-8065

Authors: Uberall, F Hellbert, K Kampfer, S Maly, K Villunger, A Spitaler, M Mwanjewe, J Baier-Bitterlich, G Baier, G Grunicke, HH

Citation: F. Uberall et al., Evidence that atypical protein kinase C-lambda and atypical protein kinaseC-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton, J CELL BIOL, 144(3), 1999, pp. 413-425

Authors: Grunicke, HH

Citation: Hh. Grunicke, Molecular basis of targeted chemotherapy: Novel concepts with special reference to the treatment of Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 125-128

Authors: Grunicke, HH Maly, K Tinhofer, I Giselbrecht, S Kampfer, S Baier, G Uberall, F

Citation: Hh. Grunicke et al., Inhibition of phospholipase C and protein kinase C by alkylphosphocholines, DRUGS TODAY, 34, 1998, pp. 3-14